跳至主要内容
临床试验/NCT02825355
NCT02825355已完成不适用

Sentinel Node Mapping With Robotic Assisted Near Infra-red Fluorescent Imaging in Women With Cervical and Endometrial Cancer

University of Southern Denmark3 个研究点 分布在 1 个国家目标入组 512 人开始时间: 2017年2月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
512
试验地点
3
主要终点
Incidence of lymphedema

研究概览

简要总结

This study aims to evaluate the effect of SLN mapping on the incidence and severity of lymphedema in women with early stage cervical and endometrial cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Study IA: Cervical carcinoma, FIGO stage IB1, cervical tumour size < 2 cm
  • Study IB: Endometrial adenocarcinoma, presumed FIGO stage I, low- and intermediate risk: Type 1 grade 1 + 2, > 50% myometrial invasion

排除标准

  • Known allergy towards ICG and/or iodine (ICG contains 5% sodium iodine)
  • Women included in other studies affecting outcome-measures of the present study

结局指标

主要结局

Incidence of lymphedema

时间窗: 3 years

Incidence of lymphedema will be assessed using patient reported outcome measures.

Severity of lymphedema

时间窗: 3 years

Severity of lymphedema will be assessed using patient reported outcome measures.

次要结局

  • Detection rate of sentinel lymph node(2 years)
  • Mapping of SLN in different types of lymph node stations(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sara Sponholtz

MD

University of Southern Denmark

研究点 (3)

Loading locations...

相似试验

Sentinel Node Mapping in Women With Cervical and... | 临床试验